key: cord-1013942-d0ma7rn5 authors: Alicja Jereczek-Fossa, Barbara; Pepa, Matteo; Zaffaroni, Mattia; Marvaso, Giulia; Bruni, Alessio; Buglione di Monale e Bastia, Michela; Catalano, Gianpiero; Riccardo Filippi, Andrea; Franco, Pierfrancesco; Antonietta Gambacorta, Maria; Genovesi, Domenico; Iatì, Giuseppe; Magli, Alessandro; Marafioti, Luigi; Meattini, Icro; Merlotti, Anna; Mignogna, Marcello; Musio, Daniela; Pacelli, Roberto; Pergolizzi, Stefano; Tombolini, Vincenzo; Trovò, Marco; Cristina Leonardi, Maria; Ricardi, Umberto; Maria Magrini, Stefano; Corvò, Renzo; Donato, Vittorio title: COVID-19 safe and fully operational radiotherapy: an AIRO survey depicting the Italian landscape at the dawn of phase 2 date: 2020-10-14 journal: Radiother Oncol DOI: 10.1016/j.radonc.2020.09.049 sha: 0914f174ee0b18be3c4fa018ff6d1db58a9c667d doc_id: 1013942 cord_uid: d0ma7rn5 • Italy experienced one of the deadliest COVID-19 outbreaks in the world (phase 1: 8th March - 3rd May 2020), and after a ten-week lockdown period, the country has slowly reopened (phase 2: 4th May 2020 – today). • A survey was administered to Italian radiation therapy (RT) departments to depict the current scenario. • During phase 1, RT departments managed to contain the contagion without massively reducing the workload. • Virtually all safety measures still hold in phase 2 and has allowed RT departments to safely restore activities and catch up on clinical backlog. • Reorganization of activities will be crucial to prevent the potential detrimental impact of a second wave of pandemic. None. Italy was the first European country heavily involved in the COrona VIrus Disease 19 (COVID-19) pandemic 1 , with 294,932 cases and more than 35,000 deaths as of 18 th September 2020 2 . Despite the severity of the pandemic in the so-called Italian phase (P) 1 (18 th March -3 rd May 2020), radiation therapy (RT) facilities in the country managed to efficiently reorganized themselves to maintain a high standard of care while minimizing the risk of contagion for patients and staff 3 . The safety measures adopted in the country had a positive impact on the epidemiological situation and allowed the authorities to relax the restrictions and introduce, on the 3 rd May 2020, the so-called P2 (4th May 2020 -today). The present study, which represents the natural evolution of a previous investigation conducted in the middle of P1 3 , aims to query the directors of Italian RT centres, through an online questionnaire, about the approach and measures undertaken during P2 of the COVID-19 pandemic to restore the normal workload and revert to a new normality. Eighty-nine anonymous questionnaires (response rate 50%) were received from 18 different Italian regions ( Figure, Supplementary Materials S1) within the permitted timeframe. Fifty centres (57.2%) reported modification in their therapeutic activity both during P1 and P2. Therapeutic and outpatient activity reorganization between P1 and P2 is summarized in Table 1 . As far as clinical activities are concerned, during P1, all the responders but 3 (3.3%) reported a reduction inferior to 30% (62, 70%) or no reduction at all (24, 27%). Transitioning from P1 to P2, 35 (39%) centres reported workload increase, 22 (25%) a complete restart of the activity and 26 (29%) no variation, while only 6 facilities (7%) reported a decrease of activity. Triage procedures put in place during P1 remained active in all facilities during P2 to limit the contagion. Analogously, with regards to admitted patients, most measures adopted during P1 were maintained during P2 (surgical masks, 89 (100%); gloves, 13 (15%); hydro-alcoholic solution prior to entry 59 (66%); interpersonal distancing, 85 (96%)). In P2 a marked increase in the supply of all PPE was registered, especially for FFP2 and FFP3 (from 49.6% to 64% and from 9.6% to 13.5%, respectively, for the radiation oncologists). Meetings were allowed as per usual in 6 (7%) centres, with restrictions (i.e. interpersonal distancing) in 68 (76%), and in remote settings in 37 (42%). Remote working solutions for non-medical staff was maintained in the transition from P1 to P2 in 37 (42%) centres, and an additional 7% (6) The previous investigation 3 revealed that the prime focus of RT centres during P1 was to guarantee the continuity and the safety of the treatments for patients with high-risk conditions, while minimizing undue risk for conditions for which care can be safely deferred. Thanks to all the adopted measures to limit contagion among staff and patients, the pandemic effect on the Italian RT centres during P1 was, ultimately, modest, with most centres (55, 61.8%) reporting no reduction or a decrease in clinical activity not higher than 10%. Therefore, the average reduction of clinical activities in Italy turned out to be much less marked than that of Europe (38% centres reporting a reduction < 80%) and US (84% centres reporting a reduction < 80%) 4 Radiotherapy in the era of COVID-19 COVID-19 Virus Pandemic -Worldometer COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology Effect of COVID-19 pandemic on practice in european radiation oncology centers Head and neck cancer radiotherapy amid COVID-19 pandemic International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic ESMO Management and treatment adapted recommendations in the COVID-19 era Management of gynecologic cancer: Choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus ESMO Management and treatment adapted recommendations in the COVID-19 era Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic The impact of Coronavirus (COVID-19) on head and neck cancer patients' care Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic -A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group